ArticleCancer cell2022
Elimination of fluorescent protein immunogenicity permits modeling of metastasis in immune-competent settings.
Abstract readLetter
In one paragraph
Article in Cancer cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.
0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed.
- CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel.Materials today. Bio · 2026Article
- Host heterogeneity shapes clonal selection and organotropism in an extranodal lymphoma mouse model.Cell death & disease · 2026Article
- Mediator subunit MED4 enforces metastatic dormancy in breast cancer.Nature cell biology · 2026Article
- The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.Nature communications · 2026Article
- Linking tumor viability and immune infiltration with dual-nucleus MRI in preclinical models.Npj imaging · 2026Article
- Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy.Journal for immunotherapy of cancer · 2026Article
- Development of immunocompetent models for primary and metastatic ER+ breast cancer.Animal models and experimental medicine · 2026Article
- Article
- Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory Properties.Research square · 2026Article
- Microglia replacement by peripheral delivery of CSF1R inhibitor-resistant hematopoietic cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2026Article
- Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.Nature communications · 2026Article
- A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors.Clinical & translational immunology · 2026Article
- Engineered macroporous gelatin scaffolds enhance lymph node fibroblastic reticular cell identity and enable diabetogenic T cell immunomodulation.Biomaterials · 2026Article
- Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model.iScience · 2025Article
- CDK12 regulates cellular metabolism to promote glioblastoma growth.JCI insight · 2025Article
- Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state.Cell reports · 2025Article
- Modelling the ageing dependence of cancer evolutionary trajectories.Nature reviews. Cancer · 2025Review
- Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis.The Journal of clinical investigation · 2025Article
- TIM3Cancer cell · 2025Article
- Modeling metastasis - leveraging novel tools to streamline discovery in advanced cancer.Disease models & mechanisms · 2025Review
5 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
11 authors.
Candice A GrzelakPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: cgrzelak@fredhutch.org.
Erica T GoddardPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Emma E LedererPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Kamya RajaramHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jinxiang DaiPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ryann E ShorPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Andrea R LimPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Graduate Program in Molecular and Cellular Biology, University of Washington, Seattle, WA, USA.
Jeanna KimPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Slobodan BeronjaHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Alister P W FunnellAltius Institute for Biomedical Sciences, Seattle, WA, USA.
Cyrus M GhajarPublic Health Sciences Division and Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: cghajar@fredhutch.org.
Funding
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasisR01AR070780 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Slobodan Beronja · 2017 to 2026
$4.2MDefining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brainR01CA252874 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GHAJAR, CYRUS M · 2020 to 2024
$2.4MNCI NIH HHS R01 CA252874NIAMS NIH HHS R01 AR070780
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsGreen Fluorescent ProteinsHumansImmunityNeoplasm MetastasisNeoplasmsT-LymphocytesGreen Fluorescent Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.